+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 30Years - 55Years
FEMALE
ID07877051

Evaluation of the Aqua Therapeutics Vapor Ablation System for Treating Abnormal Uterine Bleeding in Premenopausal Women

Led by Aqua Therapeutics, Inc. · Updated on 2026-10-30

43

Participants Needed

3

Research Sites

51 weeks

Total Duration

AI-Summary

What This Trial Is About

Abnormal uterine bleeding AUB is irregular or heavy menstrual bleeding that affects many women aged 30 to 50, impacting their quality of life. This research evaluates the Aqua Therapeutics Thermal Therapy Vapor Ablation System ATTTVAS, a device designed to treat AUB by ablating the uterine lining in premenopausal women who have completed childbearing. The study aims to assess the safety and performance of this new vapor thermal therapy technology in managing AUB caused by benign conditions. Participants will receive treatment with the ATTTVAS device, which uses vapor thermal therapy to destroy the endometrial lining. The treatment is performed as an outpatient procedure within 15 to 20 days from the start of the menstrual cycle and includes sedation with intravenous propofol and fentanyl. The study includes nine planned visitseight on-site and one remotespanning a 12-month period after treatment. Follow-up visits will monitor menstrual bleeding, pain, quality of life, and satisfaction with the procedure. Participants will undergo assessments including medical history, blood tests, menstrual calendars, and questionnaires such as the Pictorial Blood Loss Assessment Chart PBAC and Menorrhagia Impact Questionnaire MIQ. Safety will be monitored through vital signs, laboratory data, adverse event tracking, and pain rating scales. The main outcome measures focus on changes in menstrual blood loss at baseline and 12 months post-treatment, along with patient and investigator satisfaction. The total study duration for each participant is about one year.

CONDITIONS

Brief Title

A Clinical Study of the Aqua Therapeutics Thermal Therapy Vapor Ablation System in Premenopausal Women With Abnormal Uterine Bleeding

Research Team

T

Tinatin Gagua, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here